Cryo-Cell International, Inc. Quarterly report pursuant to Section 13 or 15(d)

Notes Payable (Tables)

3 Months Ended

Feb. 28, 2023

As of February 28, 2023 and November 30, 2022, the note payable obligation was as follows:


	February 28, 2023			November 30, 2022
Note payable - Susser	$	8,891,792		$	8,921,437
Unamortized debt issuance costs - Susser		(185,592	)		(191,035	)
Net note payable	$	8,706,200		$	8,730,402
Current portion of note payable	$	158,456		$	150,527
Long-term note payable, net of debt issuance costs		8,547,744			8,579,875
Total	$	8,706,200		$	8,730,402

Interest expense on the note payable for the three months ended February 28, 2023 and 2022 was as follows:


	February 28, 2023		February 28, 2022
Interest expense on notes payable - TCB	$	—	$	12,146
Interest expense on notes payable - Susser		202,475		—
Debt issuance costs - TCB		—		6,389
Debt issuance costs - Susser		5,444		—
Total interest expense	$	207,919	$	18,535